Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy. (2023)
Attributed to:
Development of AAV gene therapy for blindness caused by cone-rod dystrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/cshperspect.a041279
PubMed Identifier: 37277205
Publication URI: http://europepmc.org/abstract/MED/37277205
Type: Journal Article/Review
Volume: 13
Parent Publication: Cold Spring Harbor perspectives in medicine
Issue: 12
ISSN: 2157-1422